Summit Therapeutics Inc.

Miami, FL · Founded 2020 · CIK 0001599298 · Medtech · Public

Medical devices for orthopedic applications

summit.tech →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$569M
6 Form D · Sep 2024
24 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$11,644,000
Private capital raisedForm D · SEC$25,000,000
Private capital raisedForm D · SEC$47,400,000
Private capital raisedForm D · SEC$50,000,000
Private capital raisedForm D · SEC$199,999,998
Private capital raisedForm D · SEC$234,999,889
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1567MH ACOUSTICS, LLC——
1568Autonomous Medical Devices Inc—$72M
1569OMNIBUS MEDICAL DEVICES, LLC——
1570Summit Therapeutics Inc.—$569M
1571PULMONESCENCE DIAGNOSTICS INC.——
1572JUST HEALTH CARE, LTD. CO.——
1573FLUID SYNCHRONY, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 28 related persons
  • Valerie AndrewsDirector
  • Frank ArmstrongDirector
  • Robert BoothDirector
  • Alessandra CesanoDirector
  • Kenneth ClarkDirector
  • Stephen DaviesDirector
  • Michael DonaldsonExecutive Officer
  • Robert DugganDirector · Executive Officer
  • Glyn EdwardsDirector · Executive Officer
  • Daniel ElgerExecutive Officer
  • Rainer ErdtmannDirector
  • Camilla GrahamExecutive Officer
  • Jeff HuberDirector
  • Houbiers JosExecutive Officer
  • Ujwala MahatmeDirector
  • Jim MellonDirector
  • David PowellExecutive Officer
  • Barry PriceDirector
  • David RoblinExecutive Officer
  • Mostafa RonaghiDirector
  • Manmeet SoniDirector · Executive Officer
  • Raymond SpencerExecutive Officer
  • Ventzislav StefanovDirector
  • Elaine StrackerDirector
  • David WurzerDirector
  • Yu XiaDirector
  • Leopoldo ZambelettiDirector
  • Mahkam ZanganehDirector · Executive Officer

Patents

USPTO · 0 granted of 3
  • Kras G12D Mutation Targeting Compoundsapplication
  • KRAS G12D Mutation Targeting Compoundsapplication
  • Kras G12D Mutation Targeting Compoundsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.